Rhythm Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. 

CEO
David P. Meeker
CEODavid P. Meeker
Employees
414
Employees414
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2008
Founded2008
Employees
414
Employees414

RYTM Key Statistics

Market cap
7.24B
Market cap7.24B
Price-Earnings ratio
-33.98
Price-Earnings ratio-33.98
Dividend yield
Dividend yield
Average volume
649.80K
Average volume649.80K
High today
$107.45
High today$107.45
Low today
$104.93
Low today$104.93
Open price
$106.53
Open price$106.53
Volume
84.38K
Volume84.38K
52 Week high
$122.20
52 Week high$122.20
52 Week low
$74.50
52 Week low$74.50

Stock Snapshot

As of today, Rhythm Pharmaceuticals(RYTM) shares are valued at $105.51. The company's market cap stands at 7.24B, with a P/E ratio of -33.98.

As of 2026-07-20, Rhythm Pharmaceuticals(RYTM) stock has fluctuated between $104.93 and $107.45. The current price stands at $105.51, placing the stock +0.5% above today's low and -1.8% off the high.

The Rhythm Pharmaceuticals(RYTM)'s current trading volume is 84.38K, compared to an average daily volume of 649.8K.

During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $74.50 at its lowest and $122.20 at its peak.

During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $74.50 at its lowest and $122.20 at its peak.

RYTM News

CNN 5d
symbol__ Stock Quote Price and Forecast - CNN

...

symbol__ Stock Quote Price and Forecast - CNN
TipRanks 5d
Rhythm’s Setmelanotide Extension Study: What Long-Term Data Could Mean for RYTM

Rhythm Pharmaceuticals (RYTM) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index...

Analyst ratings

94%

of 17 ratings
Buy
94.1%
Hold
5.9%
Sell
0%

People also own

Based on the portfolios of people who own RYTM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.